About Xeris Biopharma Holdings, Inc. (XERS)
Xeris Biopharma Holdings, Inc. (XERS) is a publicly traded company in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. View real-time stock data, AI analysis, options flow, and convergence signals for XERS on iGotFomo.
XERS Key Statistics
| Current Price | $6.23 | Market Cap | $1.1 billion |
|---|---|---|---|
| Daily Change | +5.24% | Volume | 419K |
| 52-Week High | $10.08 | 52-Week Low | $4.30 |
| P/E Ratio (TTM) | 91.76 | Forward P/E | 15.51 |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
Frequently Asked Questions About XERS
- What is Xeris Biopharma Holdings, Inc. (XERS)?
- Xeris Biopharma Holdings, Inc. (XERS) is a publicly traded company in the Healthcare sector, operating in the Drug Manufacturers - Specialty & Generic industry.
- What is the current XERS stock price?
- As of the latest trading session, XERS trades at $6.23 per share, with a daily change of +5.24%.
- What is XERS's market capitalization?
- Xeris Biopharma Holdings, Inc. has a market capitalization of $1.1 billion, making it a small-cap stock.
- What sector does XERS belong to?
- Xeris Biopharma Holdings, Inc. operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. View all Healthcare stocks.